Please ensure Javascript is enabled for purposes of website accessibility

Why Moderna Stock Jumped Today

By Keith Speights - Apr 21, 2021 at 4:08PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The biotech announced a new supply deal with Israel.

What happened

Shares of Moderna (MRNA 2.58%) were jumping 7.4% higher as of 3:42 p.m. EDT on Wednesday. The gain came after the company announced that it won a new deal to supply its COVID-19 vaccine to Israel for 2022. 

So what

Moderna didn't reveal how many doses are included in its latest agreement with Israel. However, Israeli news organization Ynet reported earlier this week that Israel was buying 7.2 million doses of the company's COVID-19 vaccine for around 0.5 billion shekels, which equates to roughly $150 million.

Gloved hands holding a syringe and needle with a COVID-19 vaccine vial with the flag of Israel in the background

Image source: Getty Images.

Why did the market cap for the biotech stock rise by close to $5 billion on a new supply deal worth only a fraction of that amount? Investors could simply be overreacting to Moderna's good news.

However, it's important to note that this is the first firm order that the company has received to supply COVID-19 vaccine doses for next year. Israel previously ordered 10 million doses of Moderna's vaccine for 2021. A large order for next year could bode well for the company's prospects of winning supply agreements with other countries that aren't much lower than its 2021 deals.

Israel also retains an option to buy doses of one of the new variant-specific COVID-19 vaccine candidates that Moderna is developing pending regulatory approval.

Now what

Investors will watch closely now to see if other countries begin placing orders for Moderna's vaccine for use next year. The stock could move even higher if the company lines up major supply agreements with the U.S. and/or the European Union.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$159.56 (2.58%) $4.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
323%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.